Cited by 32Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases

Effect of Trasina ® , an Ayurvedic Herbal Formulation, on Experimental Models of Alzheimer's Disease and Central Cholinergic Markers in Rats

Bhattacharya, S.K., Kumar, A.·1997·The Journal of Alternative and Complementary Medicine

Abstract

Trasina is a herbal formulation of some Indian medicinal plants classified in Ayurveda, the classic Indian system of medicine, as Medhyarasayanas or drugs reputed to improve memory and intellect. Earlier experimental and clinical investigations have indicated that the formulation has a memory-facilitating action. In this investigation, the effect of Trasina, after subchronic administration for 21 days, was assessed on two rodent models simulating some biochemical features known to be associated with Alzheimer's disease (AD). The models, in rats, included intracerebroventricularly (i.c.v.) administered colchicine (15 micrograms/rat) and lesioning of nucleus basalis magnocellularis (nbm) by ibotenic acid (10 micrograms/rat). Retention of an active avoidance response was used as the memory parameter. In addition, the effect of Trasina was evaluated on i.c.v. colchicine-induced depletion of acetylcholine (ACh) concentrations, reduction in choline acetyltransferase (ChAT) activity, and decrease in muscarinic cholinergic receptor (MCR) binding in rat brain frontal cortex and hippocampus. The behavioral and biochemical investigations were done 7, 14, and 21 days after colchicine or ibotenic acid lesioning. Trasina (200 and 500 mg/kg) was administered orally (p.o.) once daily for 21 days, the first drug administration being given just prior to lesioning. Colchicine and ibotenic acid induced marked retention deficit of active avoidance learning that was attenuated in a dose-dependent manner by Trasina after 14 and 21 days of treatment. Frontal cortical and hippocampal ACh concentrations, ChAT activity and MCR binding was significantly reduced after colchicine treatment. Trasina (200 and 500 mg/kg) reversed these deficits after 14 and 21 days of treatment. The findings indicate that the herbal formulation exerts a significant nootropic effect after subchronic treatment that may be due to reversal of perturbed cholinergic function.

Integrity signals

Registry

Crossref · 10.1089/acm.1997.3.327

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bhattacharya, S. K., & Kumar, A.
Affiliations
  • Banaras Hindu University (IN)
  • Leipzig University (DE)
Venue
The Journal of Alternative and Complementary Medicine
Published
1997-12
Volume
3
Issue
4
Pages
327-336
ISSN
  • 1075-5535 (ISSN-L)
  • 1557-7708
OpenAlex
W1965799648
Cited by
32
References
33
Citations by year
2025: 1 · 2023: 1 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 1
FWCI
4.57
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Alternative and Complementary Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
Ayurvedic herbal formulation, Alzheimer's disease, cholinergic system, acetylcholine depletion, choline acetyltransferase, muscarinic receptor binding, active avoidance, memory impairment, nootropic effects, frontal cortex, hippocampus
MeSH terms
Acetylcholine, Alzheimer Disease, Animals, Binding Sites, Choline O-Acetyltransferase, Colchicine, Disease Models, Animal, Dose-Response Relationship, Drug, Frontal Lobe, Hippocampus, Ibotenic Acid, Male, Medicine, Ayurvedic, Phytotherapy, Memory Disorders, Plants, Medicinal, Receptors, Muscarinic, Rats, Wistar, Cholinergic Antagonists, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review